ARAV Aravive Inc

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2014
Outstanding shares:  30,518,269
Average volume:  110,454
Market cap:   $27,005,616
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.56
PB ratio:   0.51
PS ratio:   3.26
Return on equity:   -112.77%
Net income %:   -533.99%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy